BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 16, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for March 26, 2025

March 26, 2025
Additional early-stage research and drug discovery news in brief, from: Mitsubishi Tanabe Pharma, NMD Pharma, Soligenix, Tenaya Therapeutics, Tharimmune, Theralase Technologies, Traws Pharma.
Read More

Other news to note for March 25, 2025

March 25, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 23andMe Holding, Abbvie, Genmab, Mira, Profoundbio, Skny, Valneva.
Read More

Other news to note for March 25, 2025

March 25, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Fuwang, Shineco.
Read More

Other news to note for March 25, 2025

March 25, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Formosa
Read More

Other news to note for March 24, 2025

March 24, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adaptimmune, Johnson & Johnson, Macrogenics, Rarestone, Rhythm, Vantai.
Read More

Other news to note for March 24, 2025

March 24, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott, Aira Matrix, Gestalt Diagnostics, Ibex Medical, Pathai, Royal Philips.
Read More

Other news to note for March 24, 2025

March 24, 2025
Additional early-stage research and drug discovery news in brief, from: Maia Biotechnology, Precision Biosciences, Poxel, Telomir Pharmaceuticals, Traws Pharma.
Read More

Other news to note for March 21, 2025

March 21, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alvotech, Candel, Domain, Evofem, Idea, Optinose, Paratek, Windtree, Xbrane.
Read More

Other news to note for March 21, 2025

March 21, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alpha Medical, Aiforia, Autonomix Medical, Coduent, Leadoptik, Logical Images, Lucid, Menarini Group, Pathpresenter, Pavmed, Revvity, Stemline Therapeutics, Techcyte, Tetrous, Visualdx, Yaqrit.
Read More

Other news to note for March 20, 2025

March 20, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aadi, Allovir, Cargo, Kalaris, Purdue, Whitehawk.
Read More
Previous 1 2 … 54 55 56 57 58 59 60 61 62 … 1394 1395 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 15, 2026.
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 14, 2026
  • Cancer cell in the cross-hairs

    Selective CBL-B inhibitor with improved safety profile disclosed

    BioWorld Science
    CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing